Photo: Solskin/Getty Images
Alleviate Health, an AI-enabled patient recruitment company for clinical trials, has launched with a $4.3 million seed funding round led by Andreessen Horowitz alongside other investors.
WHAT IT DOES
The North Carolina-based company offers human-in-the-loop AI agents that screen patients for clinical trial participation, including engaging with patients 24/7 via SMS and voice. The company also helps verify eligibility as well as book visits and calls.
"As the teams on the ground drive trials forward, research sites need modern tools, purpose-built to turn interest into enrolled patients," Jay Rughani, investing partner at Andreessen Horowitz, said in a statement. "Alleviate gives research teams immense leverage – streamlining operations while improving the patient experience."
MARKET SNAPSHOT
Other companies offering patient recruitment services for clinical trials include Antidote Technologies, a digital patient engagement company. Last year, the company announced it was partnering with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve trial timelines.
SubjectWell is a patient recruitment platform for clinical trials. Last year, the company acquired Trials24, a global provider of digital patient recruitment tools. In 2022, SubjectWell secured $35 million in Series B funding.
